Enerzair Breezhaler (Indacaterol/Glycopyrronium/Mometasone Furoate)

Name: Enerzair Breezhaler
Brand: Novartis
SKU: 7651
Availability: InStock

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

Type:

Product: Enerzair Breezhaler

Manufacturer: Novartis

Country: Canada

Dosage: 150 mcg/50 mcg/60 mcg/30 dose

Qty-Price (USD):

Generic Equivalent of Enerzair Breezhaler

Type

Product

Manufacturer

Country

Dosage

Qty-Price (USD)

There is no generic product of Enerzair Breezhaler.

Enerzair Breezhaler Information

Enerzair Breezhaler at CanadaPharmacyOnline.com

The manufacturer of the brand-name Enerzair Breezhaler is Novartis Pharmaceuticals Canada Inc. Enerzair is a high-potency triple therapy inhaler approved by Health Canada in 2020. It combines three different medications into a single, once-daily dose delivered through the Breezhaler device.

The generic indacaterol / glycopyrronium / mometasone furoate is currently unavailable (at this pharmacy).

Dosage:

Enerzair Breezhaler is available in a standard fixed-dose strength:
• Inhaler: 150 mcg of indacaterol (as acetate), 50 mcg of glycopyrronium (as bromide), and 160 mcg of mometasone furoate per capsule.

The dosage is one capsule inhaled once daily at around the same time each day. The medication is contained in capsules that are placed into the Breezhaler device. Do not swallow the capsules. Always use the inhaler provided in the new pack.

Usage:

Enerzair is used as a maintenance treatment for asthma in adults. It is prescribed when a patient's asthma remains uncontrolled (including experiencing at least one flare-up in the previous year) despite regular use of a dual-combination inhaler. By using three different pathways, it aims to maximize lung function and prevent severe exacerbations (attacks).

Mechanism of Action
Enerzair works by simultaneously targeting the two main drivers of asthma: inflammation and airway tightening. Indacaterol is an ultra-long-acting beta2-agonist. It relaxes the muscles around the airways for a full 24 hours, keeping them open. Glycopyrronium is a long-acting muscarinic antagonist. It blocks the nervous system signals (acetylcholine) that tell the airways to constrict, providing a second layer of bronchodilation. Mometasone furoate is a potent corticosteroid. It works at the cellular level to reduce the underlying swelling and mucus production in the lungs, which makes the airways twitchy and sensitive to triggers.

Take Enerzair Breezhaler exactly as your doctor prescribes, according to the product monograph. Always rinse your mouth with water and spit it out after using the inhaler. This helps prevent oral thrush, a yeast infection of the mouth.

The information below summarizes some, but not all, potential side effects, risks, and interactions. Before starting Enerzair Breezhaler, it is essential to discuss all possible side effects, risks, and interactions with your doctor or pharmacist.

Side Effects:

The information below outlines potential side effects of Enerzair Breezhaler (indacaterol/glycopyrronium/mometasone furoate). It is not an exhaustive list, and individual reactions can vary.

Common side effects: These are common side effects of Enerzair Breezhaler; other side effects are possible. Contact your doctor promptly if any side effects are persistent, worsening, or concerning, or if you experience any other concerning symptoms.
• Common cold symptoms (nasopharyngitis)
• Dizziness
• Headache
• Muscle or joint pain
• Oral thrush (white patches in the mouth)

Serious Side Effects: Seek immediate medical attention or call emergency services if you experience any of the following symptoms:
• Allergic Reaction: Swelling of the face, lips, or tongue; difficulty swallowing; or a severe rash.
• Eye Issues: Pain or blurred vision (signs of narrow-angle glaucoma).
• Heart Problems: Fast or irregular heartbeat or palpitations.
• Paradoxical Bronchospasm: Sudden wheezing or gasping for air right after inhalation.

Contraindications:

The following is not an exhaustive list of contraindications. Before starting Enerzair Breezhaler, it is crucial to discuss all your medical conditions, past and present, and all medications you are taking with your doctor or pharmacist.

Do not take Enerzair Breezhaler/indacaterol / glycopyrronium / mometasone furoate if:
• Acute Symptoms: Do not use to treat sudden shortness of breath.
• Allergies: You have a known hypersensitivity to indacaterol, Glycopyrronium, mometasone furoate, or any of the inhaler's ingredients.

Tell your doctor about all of your medical conditions, past and present, before starting Enerzair Breezhaler. This is crucial as certain conditions affect the drug's safety.
• Glaucoma or Prostate Issues: The LAMA component of the inhaler can worsen these conditions.
• Heart Conditions: Use with caution if you have a history of heart rhythm problems or high blood pressure.
• Milk Protein Allergy: The capsules contain lactose, which may have traces of milk protein.

Drug Interactions:

Before taking Enerzair Breezhaler, discuss all potential risks and interactions with your doctor or pharmacist. For complete and up-to-date information, please visit the patient medication information at https://www.novartis.com/ca-en/sites/novartis_ca/files/enerzair%20breezhaler_patient_e_0.pdf.

Provide your doctor with a complete list of all your medications, including prescriptions, over-the-counter (OTC) drugs, vitamins, herbal supplements, recreational drugs, and any significant dietary changes, as these may interact with Enerzair Breezhaler. Enerzair Breezhaler may interact with other medicines, including but not limited to:
• Beta-Blockers: These can block the LABA component, leading to airway tightening.
• CYP3A4 Inhibitors: Drugs like ketoconazole may increase the levels of the steroid (mometasone) in your blood.
• Other Anticholinergics: Using other LAMA drugs (like Spiriva) can increase side effects.

Pregnancy and Breastfeeding:

Enerzair should only be used during pregnancy if the expected benefit to the mother justifies the potential risk to the fetus. It is not known if the ingredients pass into breast milk. Your doctor will help you decide between breastfeeding and using the medication.

Use in Children:

Enerzair Breezhaler is not approved for use in children or adolescents under 18 years of age. Its safety and effectiveness in younger populations have not been established.

Frequently Asked Questions about Enerzair Breezhaler at Canada Pharmacy Online

Why is Enerzair Breezhaler more affordable in Canada than in the United States?

Prescription drug prices, including Enerzair Breezhaler, are generally lower in Canada than in the U.S. due to a combination of factors, primarily government price regulations, differing market dynamics, and other economic considerations. In Canada, provincial and federal governments negotiate drug prices with pharmaceutical companies, which often results in lower prices than in the U.S., where market forces play a more significant role. For more information, see the FAQs on Prescription Drug Importation from the Kaiser Family Foundation (KFF): https://www.kff.org/health-costs/issue-brief/faqs-on-prescription-drug-importation/

How much is the shipping?

Our shipping fee is a flat rate of $10.00 per order. Our pharmacy is dedicated to offering you the lowest prices on high-quality products.

How do I place an order with your pharmacy?

Ordering from us is very simple. You can purchase online or call Customer Service at 1866.920.3784; for more information or to learn about the ordering process, visit our How to Order page.

Is there a limit on how many Enerzair Breezhaler I can order at once?

CanadaPharmacyOnline.com can dispense up to a three-month supply of Enerzair Breezhaler per prescription from your doctor.

Can I buy Enerzair Breezhaler from you over the counter?

No, Enerzair Breezhaler requires a valid prescription from your doctor. We do not sell this product without a valid prescription.

Do you ship to the United States?

Yes, we do. It usually takes between 7 and 18 business days to receive your order from our pharmacy.

Is there a generic for Enerzair Breezhaler?

No, the generic indacaterol / glycopyrronium / mometasone furoate is currently unavailable (at this pharmacy).

Blog Post:

Ellipta for COPD or Asthma? What You Should Know

Latest News:

Climate change is making outdoors challenging for people with asthma (news published on April 20, 2026)

Similar Drugs in the category of Asthma Medication/ Respiratory Disorders:

Flovent Inhaler Advair Symbicort Inhalation Aerosol Spiriva Caps and Device Albuterol

The information on this page is sourced from independent third parties contracted by CanadaPharmacyOnline. While we cannot guarantee its medical accuracy, we strongly recommend consulting a healthcare professional for personalized advice regarding medications or medical conditions.

Reviews From Real Customers